


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31200059</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>06</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1615-5947</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Jun</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of vascular surgery</Title>
                <ISOAbbreviation>Ann Vasc Surg</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Treatment of critical limb ischaemia by pIRES/VEGF165/HGF administration.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S0890-5096(19)30367-X</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.avsg.2019.03.013</ELocationID>
            <Abstract>
                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Prognosis of peripheral artery disease (PAD), especially critical limb ischaemia (CLI), is very poor despite the development of endovascular therapy and bypass surgery. Many patients result in leg amputation. We decided to investigate the safety and efficacy of pIRES/VEGF165/HGF gene therapy (GT) in patients suffered from CLI.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Administration of pIRES/VEGF165/HGF was performed in 12 limbs of 12 patients with rest pain and ischaemic ulcers due to CLI. Plasmid was injected into the muscles of the ischaemic limbs. The levels of VEGF in serum and the ankle-brachial index (ABI) were measured before and after treatment.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Mean (±SD) plasma levels of VEGF increased non-significantly from 258 ± 81 pg/L to 489 ± 96 pg/L (P &gt;0.05) 2 weeks after therapy and the ABI improved significantly from 0.27 ± 0.20 to 0.50 ± 0.22 (P &lt;0.001) 3 months after therapy. Ischaemic ulcers healed in 9 limbs. Amputation was performed in 3 patients because of advanced necrosis and wound infection. However, the level of amputations was lowered below knee in these cases. Complications were limited to transient leg oedema in 3 patients and fever in 2 patients.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Intramuscular administration of pIRES/VEGF165/HGF is safe, feasible and effective for patients with critical leg ischaemia.</AbstractText>
                <CopyrightInformation>Copyright © 2019. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Barć</LastName>
                    <ForeName>Piotr</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department and Clinic of Vascular, General and Transplantation Surgery, Jan Mikulicz-Radecki Medical University Hospital, Wroclaw Medical University, Wroclaw, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Antkiewicz</LastName>
                    <ForeName>Maciej</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department and Clinic of Vascular, General and Transplantation Surgery, Jan Mikulicz-Radecki Medical University Hospital, Wroclaw Medical University, Wroclaw, Poland. Electronic address: maciej.antkiewicz@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Śliwa</LastName>
                    <ForeName>Barbara</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department and Clinic of Vascular, General and Transplantation Surgery, Jan Mikulicz-Radecki Medical University Hospital, Wroclaw Medical University, Wroclaw, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Baczyńska</LastName>
                    <ForeName>Dagmara</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Techniques Unit, Wroclaw Medical University, Wroclaw, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Witkiewicz</LastName>
                    <ForeName>Wojciech</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Regional Specialized Hospital in Wroclaw, Research and Development Center, Wroclaw, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Skóra</LastName>
                    <ForeName>Jan Paweł</ForeName>
                    <Initials>JP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department and Clinic of Vascular, General and Transplantation Surgery, Jan Mikulicz-Radecki Medical University Hospital, Wroclaw Medical University, Wroclaw, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Ann Vasc Surg</MedlineTA>
            <NlmUniqueID>8703941</NlmUniqueID>
            <ISSNLinking>0890-5096</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">HGF</Keyword>
            <Keyword MajorTopicYN="N">VEGF</Keyword>
            <Keyword MajorTopicYN="N">gene therapy</Keyword>
            <Keyword MajorTopicYN="N">thromboangiitis obliterans</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>03</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>03</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31200059</ArticleId>
            <ArticleId IdType="pii">S0890-5096(19)30367-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.avsg.2019.03.013</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

